Incyte (INCY) Enterprise Value Growth (5y) (2015 - 2026)
Incyte (INCY) Enterprise Value Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.40% |
| Dec 31, 2025 | -14.73% |
| Sep 30, 2025 | -11.05% |
| Jun 30, 2025 | -8.79% |
| Mar 31, 2025 | -13.08% |
| Dec 31, 2024 | -0.38% |
| Jun 30, 2024 | 9.02% |
| Mar 31, 2024 | -19.49% |
| Dec 31, 2023 | -20.51% |
| Sep 30, 2023 | -20.65% |
| Jun 30, 2023 | -61.35% |
| Mar 31, 2023 | -56.75% |
| Dec 31, 2022 | -22.59% |
| Sep 30, 2022 | -18.36% |
| Jun 30, 2022 | -34.93% |
| Mar 31, 2022 | -37.80% |
| Dec 31, 2021 | -23.77% |
| Sep 30, 2021 | -26.09% |
| Jun 30, 2021 | -33.67% |
| Mar 31, 2021 | -19.34% |